Ethical Consumer: What Happened With Zantac

Monday, February 17, 2020

What Happened With Zantac

Zantacs active ingredient ranitidine HCl metabolizes into NDMA or N- Nitrosodimethylamine. Several countries around the world are taking steps to restrict sales of Zantac and generics that are made of ranitidine a popular acid reducer because the FDA and European regulators learned about a link between this medication and the potentially dangerous chemical NDMA scientific name N-Nitroso-dimethylamine.

Zantac Pulled From Shelves By Walgreens Rite Aid And Cvs Over Carcinogen Fears The New York Times

NDMA acts as a carcinogen by modifying DNA and causing inflammation resulting in tumor growth and promotion.

What happened with zantac. In 2019 independent pharmacy Valisure found an issue with ranitidine the active ingredient in Zantac. Traces of the impurity N-nitrosodimethylamine NDMA are found in some foods and water supplies but can be dangerous at higher concentrations. The story is unfolding quickly and many details remain murky.

In late 2019 an independent lab first discovered NDMA contamination in Zantac and generic ranitidine findings that were later confirmed by the Food and Drug Administration FDA. Zantac Breast Cancer Link There is also anecdotal evidence that Zantac use might be linked to breast cancer. At its height the drug was prescribed 15 million times per year.

Zantac and ranitidine have made numerous headlines in recent weeks after the Food and Drug Administration FDA decided to investigate possible contaminants in ranitidine products on September 13. Symptoms of pneumonia include chest pain fever feeling short of breath and coughing up green or yellow mucus. Talk with your doctor about your specific risk of developing pneumonia.

Studies have linked this hepatotoxin to cancer in both animals and humans. UK doctors are being told to stop prescribing four types of a heartburn medication called Zantac or ranitidine as a precautionary measure. According to the FDA all ranitidine products including the oral liquidsyrup will be removed by their manufacturers and will not be available in the US.

This isnt some new bad manufacturing process overseas like. Valisure tests every single batch of drugs before sending them to consumers rejecting more. The FDA announced an official market withdrawal of Zantac on April 1 2020.

What Happened With Zantac. The pharmacy chains announced this week that they were no longer selling the product after the Food and Drug Administration issued a statement in mid-September saying that Zantac and its generic form ranitidine may contain low levels of N-nitrosodimethylamine NDMA a nitrosamine impurity. Zantacs risk appears to be the unstable nature of the drug itself said Valisure CEO David Light.

The study linked increasing NDMA levels to the degradation of hydrochloride molecules in Zantac. The concerns over the lack of testing on foreign-produced drugs can be clearly seen in the case of Zantac. Oct 18 2019 Sanofi recalls over-the-counter Zantac in the United States and Canada a day after the UK unit of Teva Pharmaceutical the worlds largest generic drug maker recalled.

NDMA in Zantac represents a serious cancer risk. This increase occurred in both men and women. A Zantac lawsuit is a legal claim for financial compensation by plaintiffs who took the heartburn medication and were later diagnosed with cancer.

If you or a family member take ranitidine Zantac to relieve heartburn you may have heard that the FDA has found a probable human carcinogen a substance that could cause cancer in it. Using Zantac may increase your risk of developing pneumonia. Monday pharmacy chains CVS and Walgreens announced they would suspend sales of Zantac brand pills and generic versions that contain ranitidine.

Zantac recalls were almost immediately issued and popular pharmacies removed Zantac and ranitidine from their shelves. In December 2020 another study came out to give us a clear picture of what happened with Zantac and NDMA. It also lends new credence to the theory that heat that is created when ingesting the drug might contribute to the process that increases the NDMA.

Zantac and the generic version ranitidine have been found to contain the carcinogen NDMA. Since the 1970s NDMA is a chemical that the FDA and WHO have classified as a cancer-causing carcinogen. New Zantac Studies in 2020 and 2021.

It follows concern in several countries that products. According to the FDA NDMA has been classified as a probable human carcinogen based. In 2008 a study showed that ranitidine and Zantac increased the risk of ductal carcinoma by more than two-fold.

Should You Keep Taking Zantac For Your Heartburn The New York Times